BONESUPPORT: Study Affirms Cerament Remodels into Human Bone
Retrospective review of 163 patients at one-year follow-up revealed clinical evidence of BONESUPPORT's CERAMENT® bone void filler remodeling into bone...
Apr 11, 2019,
BONESUPPORT: Study Affirms Cerament Remodels into Human Bone
NuVasive Debuts X360 System for Lateral Single-Position Spine Procedures
NuVasive is introducing the X360 system integrated with Pulse automation for lateral single-position surgery. ...
Apr 11, 2019, Julie Vetalice
HAPPE Spine Announces Second Financing Round
HAPPE Spine received a second round of financing. The company is developing material technology that allows for the construction of partial...
Apr 11, 2019, Julie Vetalice
Barricaid Completes $52MM Financing to Support Barricaid
Intrinsic Therapeutics completed a US $52MM equity financing. Proceeds will support U.S. commercialization of the Barricaid® anular closure device....
Apr 11, 2019, Julie Vetalice
NASS Review: Spinal Robotics, Enabling Technologies, 3D Printing and Biologics
Enabling technology was the story of the North American Spine Society 2019 annual meeting (NASS), with the top spine players...
Apr 10, 2019, Mike Evers
Treace Medical: Lapiplasty 3D Bunion Correction Study Results
Treace Medical Concepts announced additional positive clinical data supporting the Lapiplasty® 3D Bunion Correction procedure....
Apr 09, 2019, Julie Vetalice
Osso VR Surgical Training Expands to Europe
Osso VR announced expansion to the European market following adoption of its virtual reality surgical training platform in the U.K....
Apr 09, 2019, Julie Vetalice
Alphatec Secures Additional $30MM Funding
Alphatec will receive US $30MM in secured debt financing from Squadron Capital. Proceeds will support company growth....
Apr 09, 2019, Julie Vetalice
Medacta Group SA Prices IPO at CHF 96 (USD $96.1) Per Share
Medacta launches IPO with base size of CHF 547MM (USD $547.8MM), with 5.7 million shares offered at a price of...
Apr 05, 2019, Julie Vetalice
Orthofix M6-C Artificial Cervical Disc Study: Full 2-Year Data
Full 2-year outcomes from a U.S. IDE study of Orthofix Medical's M6-C artificial cervical disc demonstrated that disc replacement with...
Apr 04, 2019, Julie Vetalice
Loading new posts...
No more posts
